Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of Patients Previously Treated With Autologous T Cells Genetically Modified With Viral Vectors

NCT03628612 is registered in ClinicalTrials.gov with Autolus Limited as lead sponsor.

NCT NCT03628612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03628612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of Patients Previously Treated With Autologous T Cells Genetically Modified With Viral Vectors
Lead sponsor
Autolus Limited
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
August 2, 2018
Completion date
December 31, 2043
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

all, adult and pediatric, dlbcl, multiple myeloma, patients followed for up to 15 years following their first dose of auto car t cell therapy, t cell lymphoma